The significance of dermatoglyphics in medicine. A short survey and summary.
D000014:Abnormalities, Drug-Induced; D002869:Chromosome Aberrations; D025063:Chromosome Disorders; D002901:Chromosomes, Human, 13-15; D002902:Chromosomes, Human, 16-18; D002904:Chromosomes, Human, 21-22 and Y; D000013:Congenital Abnormalities; D003878:Dermatoglyphics / Q000266:history; D005060:Europe; D005260:Female; D005826:Genetics, Medical; D005865:Gestational Age; D049670:History, 17th Century; D049671:History, 18th Century; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000150:complications; D044469:Racial Groups; D012409:Rubella / Q000150:complications; D012729:Sex Chromosome Aberrations; D012737:Sex Factors; D012867:Skin / Q000254:growth & development; D013792:Thalidomide / Q000009:adverse effects; D014314:Trisomy; D014427:Twins; D014481:United States
D013792:Thalidomide